Trial Profile
A population based cohort study to compare rates of treated herpes zoster, hepatitis C (HepC), and tuberculosis (TB) among patients with psoriasis treated with Apremilast, Biologics, Conventional Systemics, and Corticosteroids.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 May 2018
Price :
$35
*
At a glance
- Drugs Apremilast (Primary)
- Indications Psoriasis
- Focus Therapeutic Use
- 08 May 2018 New trial record